Pregnant and breastfeeding women concerns during a group B Streptococcus phase II clinical trial: a qualitative study in Kampala, Uganda

Despite evidence that maternal vaccines can contribute to reduction of neonatal infections, vaccine hesitancy is a challenge in many low- and middle-income countries like Uganda.

We conducted in-depth interviews with pregnant women and focus group discussions with breastfeeding women who were part of a Group B Streptococcus (GBS) clinical trial. We explored the women’s concerns about vaccination and their reasons for being hesitant to take vaccines before they joined the trial. Women aged 18–39 were randomly selected from follow-up lists during the study period. Data were analysed thematically.

All the women had been hesitant about joining the trial because of fear of possible vaccine side effects. A lack of knowledge on maternal vaccines, rumours and stigma in the community as well the need to follow study procedures were other concerns. Several women were concerned about their male partner view of their trial participation because using a trial vaccine meant taking a decision on behalf of the foetus.

Pregnant women’s involvement in clinical trials of maternal immunisation requires engagement with their families and community stakeholders, including local leaders and health workers, to ensure people understand what maternal vaccines are and why trials with pregnant women are required.